Find your path to Jason
1,036 people in our graph share verified history with Jason — schools, employers, funds. One of them is your warm intro.
Paul KwanunlockedJason: together at Stanford University (2024–2026)
×5Jason: together at University of California, Berkeley
Jason: together at Stanford University
Jason: together at University of San Francisco
About
Before joining Maze in 2019, he was a venture partner at Third Rock Ventures and spent nearly a decade at Roche, rising to vice president, following earlier bench work as a scientist at Cytokinetics. He also lectures and advises students at Stanford University and USC's Mann Division of Healthcare and Biopharmaceutical Business.
Chief Executive Officer at Maze Therapeutics
Intro paths
→
In turn, Jason can intro founders to Maze Therapeutics's investors below.
Maze Therapeutics's investors · 9
Andreessen HorowitzMenlo Park · $500K – $50M checksARCH Venture PartnersChicago · $50K – $250M checksForesite CapitalWest HollywoodFrazier Life SciencesPalo Alto · since 2025GV (Google Ventures)Mountain View · $250K – $50M checksJanus Henderson InvestorsLondon · since 2025SignalFireSan Francisco · $250K – $15M checks · since 2019Third Rock VenturesBoston · $100K – $5M checks · since 2019Venrock Healthcare Capital PartnersNew York · since 2025
Co-founders at Maze Therapeutics
CH
Charles HomcyDirector
Experience
- Maze TherapeuticsChief Executive Officercurrent2019 — presentSouth San Francisco, California
- USC Mann Division of Healthcare and Biopharmaceutical BusinessStudent Advisor, Guest Lecturercurrent2024 — present
- Stanford UniversityGlobal Advisor, Guest Lecturercurrent2024 — presentPalo Alto, California, United States
- Third Rock VenturesVenture Partner2016 — 2019San Francisco, California
- RocheVice President2007 — 2016Basel, Switzerland and SSF, CA
- CytokineticsScientist2002 — 2005South San Francisco, California, United States
Skills & more
Biotechnology23Strategy33Lifesciences5Business Development19Infectious Diseases2Market Analysis3Venture Capital9Medical Devices3Commercialization6Oncology7Product Launch3Pharmaceutical Industry13
+9 more
Strategic PlanningPortfolio ManagementCross-functional Team LeadershipLicensingStart-upsMarket ResearchCompetitive AnalysisClinical TrialsLife SciencesFrom Jason's professional profile.
Frequently asked questions
- Who is Jason Coloma?
- Before joining Maze in 2019, he was a venture partner at Third Rock Ventures and spent nearly a decade at Roche, rising to vice president, following earlier bench work as a scientist at Cytokinetics. He also lectures and advises students at Stanford University and USC's Mann Division of Healthcare and Biopharmaceutical Business.
- Where does Jason Coloma work?
- Jason Coloma is Chief Executive Officer at Maze Therapeutics.
- Where did Jason Coloma go to school?
- Jason Coloma studied at The Tuck School of Business at Dartmouth (MBA, General Management); University of California, Berkeley; University of San Francisco.
Founder mafias
Stanford University mafia1,934
Also came through, then founded or led a company.
Peter ThielB.A.Founded PayPalReid HoffmanB.S.Founded LinkedIn +2David SacksB.A.Founded YammerKeith RaboisB.A.Founded OpendoorGarry TanBSFounded Y Combinator +1Joe LonsdaleBSFounded Opto +5
+ 1,927 more
The Tuck School of Business at Dartmouth mafia66
Also came through, then founded or led a company.
Jeffrey DeFlavio, MDMaster of Business Administration (MBA)Founded Affect Therapeutics +5Errik AndersonMBAFounded Cantai Therapeutics +5Jeong-Suh ChoiMBAFounded 株式会社MEAL FORWARD +2Frank StonebanksBusiness DiplomaFounded Johnson & Johnson +1Samantha TruexMBAFounded Upstream Bio +1Aakhil FardeenMBAFounded Lish +1
+ 59 more
University of San Francisco mafia37
Also came through, then founded or led a company.
Lip-Bu TanHonorary Doctor's DegreeFounded Walden Catalyst +2Wei GuoBSFounded UpHonest Scouts +1Pierce OgdenBSFounded Manifold Biotechnologies +1Lori MazanMAFounded Joinskye +1John WitchelMSFounded King +1Rebecca GaldosBachelor of ScienceFounded Finjan Holdings
+ 30 more
Third Rock Ventures mafia23
Also came through, then founded or led a company.
Christoph LengauerPartnerFounded Celsius Therapeutics +3Reid HuberPartnerFounded MOMA Therapeutics +2Alexis BorisyPartnerFounded Foundation Medicine +2Steve PaulVenture PartnerFounded Voyager Therapeutics, Inc. +1Philip ReillyVenture PartnerFounded Luna Genetics +1Uday KumarEntrepreneur-in-ResidenceFounded Element Science +1
+ 16 more
Cytokinetics mafia2
Also came through, then founded or led a company.
Same school
Also attended The Tuck School of Business at Dartmouth325
John McCulloughInvestor at OpenView Venture PartnersCarley PhillipsPrincipal at GreycroftM.G. ThibautFormer Chief Financial Officer at DroneDeploy at Scale Venture PartnersLiam DonohueInvestor at .406 VenturesGraham BrooksPartner at .406 VenturesJoanna Skoler GilmanChief Marketing and Communications Officer at .406 Ventures
+ 319 more
Also attended University of California, Berkeley2,000
Steve WozniakCo-founder of AppleAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksAbraham BachrachCo-founder & CTO of SkydioTrevor OelschigInvestment Team at General CatalystScott DavisInvestor at GV (Google Ventures)
+ 1,994 more
Also attended University of San Francisco131
Ashley ValentineChief People Officer at GreycroftCarmen PalafoxFounder & General Partner at 2045 VenturesEugene MalobrodskyManaging Partner at One Way VenturesDaniel ShermanInvestor at Initialized CapitalRobert LindseyInvestor at Initialized CapitalBarmak MeftahGeneral Partner at Ballistic Ventures
+ 125 more
Shared employers
Also worked at Maze Therapeutics12
Jeffrey FinerVenture Partner at Third Rock VenturesVyas RamananVenture Partner at Third Rock VenturesMellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyMike VanAssociate, Private Equity at Sofinnova VenturesSudhir AgrawalInvestor at 82VSHugo HiltonPrincipal at Third Rock Ventures
+ 6 more
Also worked at Third Rock Ventures91
Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesLee VeneziaInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock Ventures
+ 85 more
Also worked at Roche229
Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized Capital
+ 223 more
Also worked at Cytokinetics6
Jeffrey FinerVenture Partner at Third Rock VenturesSoyoung ParkGeneral Partner at 1004 Venture PartnersDavid DrubinChair of Berkeley Molecular and Cell Biology at Berkeley FrontierSylvaine CasesCBO at EnodaStefan RyserPresident and Chief Executive Officer at Trellis BioscienceAlan RussellDirector at Edgewise Therapeutics
